This website uses cookies to improve your experience. You can accept or reject analytics cookies
National Cancer Control Plan 2030
CancerNational Control Plan2022
CzechiaEnglishPDF
National
AI-Generated Document Summary
Objectives
The Pandemic Plan of the Czech Republic provides a whole-of-government and whole-of-society framework for preparedness, response and recovery for influenza pandemics and comparable emerging infectious-disease threats. Its overarching purpose is to reduce deaths and health impacts, mitigate social and economic disruption, preserve essential public services, and restore healthcare, social and material capacity after pandemic waves.
Strengthen early warning, surveillance, laboratory diagnosis and rapid reporting of unusual respiratory disease, deaths, new influenza variants and human infections with novel subtypes.
Limit or delay transmission through proportionate containment or mitigation measures, vaccination, antiviral treatment, infection prevention, personal hygiene and social-hygiene interventions.
Maintain accessible healthcare, including outpatient, hospital, intensive-care, diagnostic and treatment capacity, while protecting healthcare personnel and other essential workers.
Protect human rights and address the needs of vulnerable or minority groups through ethical decisions balancing equality, benefit, freedom, reciprocity and solidarity.
Preserve the continuity of energy, water, food and agriculture, transport, communications, finance, public administration, emergency and social services, security and other essential functions.
Communicate credible, consistent and accessible information to professionals, the public, communities and hard-to-reach groups on risks, prevention, services and response measures.
Align national preparedness with the International Health Regulations (2005), World Health Organization guidance and European Union coordination arrangements, while adapting measures to Czech legal and operational conditions.
Apply a phased approach spanning pre-pandemic preparedness, pandemic waves, post-peak management, possible further waves and post-pandemic recovery.
Implementation
Implementation is organised as a multisectoral, phased response led nationally by government and health authorities, with ministries, regions, healthcare providers, laboratories, essential-service operators, crisis-management bodies, communities and international partners translating the national framework into operational pandemic plans. Decisions should be informed by surveillance, scientific evidence, feasibility and rapid assessment of epidemiological, technical, operational and medical circumstances.
Coordinate national preparedness through the Government, which decides on human, material and economic resources and cross-sector measures, and through the Commission for dealing with the incidence of serious infectious diseases, also known as the Central Epidemiology Commission.
Establish and coordinate regional commissions and pandemic plans, with regions and responsible departments setting arrangements to sustain essential services and implement local measures.
Use World Health Organization pandemic phases and assessments from the World Health Organization, European Commission and European Centre for Disease Prevention and Control to determine whether containment remains feasible or mitigation is required.
Maintain integrated clinical, virological, epidemiological and, where needed, epizootological surveillance, including investigation of clusters, deaths, animal infections, human-to-human transmission and risks of animal-to-human spread.
Report and share information nationally and internationally through the International Health Regulations, the European Union Early Warning and Response System, the European Centre for Disease Prevention and Control’s TESSy system and the World Health Organization’s FLU-NET system.
Strengthen laboratory networks through safe sample collection, storage and transport; rapid diagnostic capacity; virus characterisation and sequencing; and monitoring of antiviral resistance and pathogenicity.
Prepare healthcare and wider services for rapid increases in consultations, admissions, intensive-care demand, mechanical ventilation needs, workforce absence and constrained availability of vaccines, antivirals and other treatments.
Secure and distribute personal protective equipment, antiviral medicines, other medical supplies, and pre-pandemic or pandemic vaccines for selected patient groups and essential-service employees, subject to availability and national priorities.
Implement proportionate public-health measures, potentially including voluntary isolation, contact tracing, infection-control arrangements, limits on gatherings, school closures, travel-related measures and alternative care or isolation facilities.
Operate structured risk communication through designated health and government spokespersons, media briefings, websites, targeted information channels and communication exercises, using feedback from the public and partner organisations to refine strategies.
Review preparedness through exercises, capacity assessments and pandemic-plan revision at least every two years or whenever necessary, incorporating lessons from real events and updating protocols, case definitions and recommendations.
Assess resource needs for laboratory services, healthcare, protective equipment, medicines, vaccines and essential services; the plan identifies this requirement but does not provide a dedicated budget or quantified funding allocation.
Support recovery after pandemic peaks by restoring essential services, replenishing stocks, continuing vaccination where appropriate, addressing psychological and workforce needs, assessing response effectiveness and incorporating lessons into future preparedness.
Monitoring & Evaluation
The plan establishes a comprehensive monitoring and evaluation system for pandemic influenza, combining continuous epidemiological, clinical, virological and laboratory surveillance with national and international reporting, periodic preparedness review, and coordinated decision-making by health, government and regional authorities.
Monitor influenza and influenza-like illness throughout the year, with seasonal surveillance generally operating between calendar weeks 40 and 18 to 20, and use morbidity data to identify trends and potential epidemic development.
Collect clinical, virological and epidemiological data on seasonal influenza to estimate potential pandemic needs, including acute respiratory infections, influenza-like illness, unusual respiratory clusters, related deaths and possible human-to-human transmission.
Detect, investigate and report suspected or laboratory-confirmed human cases, identify animal influenza infections and potential sources of exposure, and assess risks of transmission from animals to humans.
Maintain laboratory capacity for safe sample collection, storage, transport, testing, virus characterisation and monitoring of antiviral resistance; use regional institutions and outpatient clinics to submit surveillance samples to the National Reference Laboratory for Influenza.
Submit national surveillance data to the European Centre for Disease Prevention and Control’s TESSy system and the World Health Organization’s FLU-NET, and share required information through the International Health Regulations and the European Union Early Warning and Response System.
Use World Health Organization and European Union case definitions, international recommendations, expert consultation and theoretical modelling to assess pandemic risk, severity, disease spread and the likely impact of interventions.
Evaluate whether community transmission is effective and whether containment remains feasible, shifting towards mitigation when the virus is too widespread for containment measures to be effective.
Track morbidity, mortality, geographic spread, high-impact groups, absenteeism, healthcare-worker availability, inpatient capacity, medical supplies, alternative care facilities and funeral-service capacity during a pandemic.
Assess the effectiveness of public-health measures, communications, antiviral treatment, vaccine coverage, vaccine safety and efficacy, antiviral resistance, and healthcare-system response.
Report epidemiological developments and their consequences to the government through the Central Epidemiology Commission, which coordinates regional commissions and recommends nationwide public-health measures.
Conduct preparedness exercises, verify pandemic information systems and communication arrangements, assess capacities, and revise the pandemic plan at least every two years or sooner when required.
Update plans, case definitions, diagnostic algorithms, treatment protocols and communication strategies in response to new findings, real events, exercises and feedback from the public and partner organisations.
Quantitative performance indicators, consolidated reporting deadlines, independent evaluation arrangements and formal accountability sanctions are not specified in the supplied material.
Costing & Financing
The plan identifies substantial resource and economic implications of pandemic influenza, including the need to secure personnel, laboratory capacity, protective equipment, vaccines, antiviral medicines, healthcare capacity and essential-service continuity. It does not provide a dedicated monetary budget, detailed financing mechanism, quantified funding gap or costed implementation plan.
Assign decisions on human, economic and material resources, including preparedness-capacity improvements, to the government, while requiring national and regional authorities to identify the human and financial resources needed for response planning.
Plan resources for personal protective equipment, pre-pandemic and pandemic vaccines, antiviral medicines, containment measures, strengthened laboratory diagnosis and analysis, and increased stocks of medicines and medical materials.
Prepare procurement, distribution and rapid use of vaccines, medicinal products and protective equipment for selected patient groups and employees of essential public services; the Ministry of Finance is involved in vaccine purchase, distribution and application.
Apply procedures for the rational, ethical and transparent use of human, material and economic resources, including workforce mobilisation and assessment of potential international assistance.
Consider reimbursement of influenza-pandemic costs affecting the state budget in line with European Commission recommendations, with responsibility assigned to the Government and Ministry of Finance.
Recognise economic disruption from illness-related absenteeism, caring responsibilities, school closures, transport disruption, reduced production and distribution, and pressure on essential services.
Estimate that a pandemic lasting about 90 days could reduce annual gross domestic product by 1.5% to 2.0%, rising to at least 2.5% to 3.0% with insufficient planning and ineffective response; longer-term effects of illness and deaths are excluded from these estimates.
Review post-peak resource and capacity requirements, stocks and service provision, and determine whether financial support is needed, including criteria and options for securing required resources.
No currency-denominated expenditure, allocation, unit cost, financing source or quantified funding shortfall is specified.